Novo Nordisk Inc.
Novo Nordisk Inc. (United States) has DMF or CEP filings on record for 3 active ingredients and is linked to 7 FDA-registered manufacturing sites. 23 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Novo Nordisk Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/novo-nordisk-inc
Overview
Novo Nordisk Inc. is a leading global healthcare company and a subsidiary of Novo Nordisk A/S. The company is renowned for its leadership in diabetes care and also provides therapies for obesity, hemophilia, growth disorders, and hormone replacement therapy.
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which Novo Nordisk Inc. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
Registered manufacturing sites (7)
Physical sites registered with the US FDA and resolved to Novo Nordisk Inc., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
- Novo Nordisk A/SKalundborg, Denmark · API manufactureSite GMP match
- Novo Nordisk A/SBagsvaerd, Denmark · API manufactureSite GMP match
- Novo Nordisk A/S - 25a-BHilleroed, Denmark · API manufacture
- Novo Nordisk A/S - HaxGentofte, Denmark · API manufacture
- Novo Nordisk Pharmaceutical Industries, LPClayton, United States · API manufacture
- Novo Nordisk Pharmatech A/SKoge, Denmark · API manufactureSite GMP match
- Novo Nordisk US Bio Production Inc.West Lebanon, United States · API manufacture
FDA compliance signals
23 FDA enforcement records linked to this company.
- warning_letter2026-03-05
FDA Warning Letter (drug product)
- recall — Class II2026-01-07
Presence of Particulate Matter: Hair was found in a prefilled syringe
- recall — Class II2026-01-07
Presence of Particulate Matter: Hair was found in a prefilled syringe
- warning_letter2025-09-09
FDA Warning Letter (drug product)
- 4832025-02-07
Late submission of an ICSR
- 4832025-02-07
Late submission of 15-day report
- 4832025-02-07
Failure to develop written procedures
- 4832025-02-07
Failure to investigate serious, unexpected events
- recall — Class II2021-04-21
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
- recall — Class II2021-04-21
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
- recall — Class I2021-04-21
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
- recall — Class I2021-04-21
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
- recall — Class I2021-04-21
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
- recall — Class II2021-04-21
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
- recall — Class I2021-04-21
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
- recall — Class I2021-04-21
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
- recall — Class I2021-04-21
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
- recall — Class I2021-04-21
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
- recall — Class I2021-04-21
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
- recall — Class I2021-04-21
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
- recall — Class I2021-04-21
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
- recall — Class I2016-12-28
Defective delivery system: detached needles on the syringe in the kit.
- recall — Class II2016-06-15
Defective Delivery System; may have a low frequency assembly fault which may result in pens block during the so-called "air shot" step
Is this Novo Nordisk Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.